SpringerLink
Log in

Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Brazil)

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166–175.

    Article  CAS  Google Scholar 

  2. Ganly P, Walker LC, Morris CM . Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk Lymphoma 2004; 45: 1–10.

    Article  CAS  Google Scholar 

  3. Horwitz M, Benson KF, Li FQ, Wolff J, Leppert MF, Hobson L et al. Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21–23.2. Am J Hum Genet 1997; 61: 873–881.

    Article  CAS  Google Scholar 

  4. De Lord C, Powles R, Mehta J, Wilson K, Treleaven J, Meller S et al. Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. Brit J Haemat 1998; 100: 557–560.

    Article  CAS  Google Scholar 

  5. Arepally G, Rebbeck TR, Song W, Gilliland G, Maris JM, Poncz M . Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML). Blood 1998; 92: 2600–2602.

    CAS  PubMed  Google Scholar 

  6. Escher R, Hagos F, Michaud J, Sveen L, Horwitz M, Olopade OI et al. No evidence for core-binding factor CBFbeta as a leukemia predisposing factor in chromosome 16q22-linked familial AML. Leukemia 2004; 18: 881.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the family for their participation in the study and to Ray Powles. The work was supported by grants from the Leukaemia Research Fund and Cancer Research UK.

Author information

Authors and Affiliations

  1. Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK

    G S Sellick & R S Houlston

  2. Section of Paediatrics, Institute of Cancer Research, Sutton, Surrey, UK

    K Pritchard-Jones

  3. Leukaemia Unit, The Royal Marsden Hospital, Sutton, Surrey, UK

    V Shepherd

  4. Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

    J Swansbury & D Catovsky

Authors
  1. G S Sellick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Pritchard-Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Shepherd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Swansbury
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Catovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R S Houlston
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R S Houlston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sellick, G., Pritchard-Jones, K., Shepherd, V. et al. Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML. Leukemia 19, 465–466 (2005). https://doi.org/10.1038/sj.leu.2403648

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403648

  • Springer Nature Limited

This article is cited by

Search

Navigation